# Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy

> **NCT01917149** · PHASE4 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 480 (actual)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DRUG:** Benazepril
- **DRUG:** Valsartan
- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT01917149
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2013-07
- **Final completion:** 2013-12
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2014-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01917149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01917149, "Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01917149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*